Digital Mental Integrated Intervention Technology on Language Improvement on Autistic Patients

December 9, 2025 updated by: Makari masri isaac mousa, Ain Shams University

Assessment of Digital Mental Integrated Intervention Technology on Language Improvement in Children of Autism: One Centre Study

Primary aim: evaluate the effect of MITA application on language improvement in children with Autism.

Secondary aim: evaluate the effect of MITA application on sociability and cognitive awareness in children with Autism.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

One of the most important behavioral and developmental features that suggest autism is language delays and deviations, so that social communication and social interaction is a real challenge during management of ASD patients.

Among individuals diagnosed with autism spectrum disorder ASD, the prevalence of prefrontal synthesis (PFS) paralysis is 30 to 40% ,and may be as high as 60% among children enrolled into special ASD schools The management of ASD is mainly non-pharmacological like cognitive, behavioral, speech therapy which may help to maximize communication skills The use of technology in the delivery of much needed therapy called digital therapeutics promises to be effective for shrinking the gap between the therapy that is recommended for children with ASD and the amount they receive. There has been a promising trend towards computer-based interventions which capitalize on the often observed preference children with ASD show for flat screen information.

Mental imaginary therapy for autism MITA application hypothesized to be used in early PFS-targeting intervention can improve language ability in children with ASD .

Study Type

Observational

Enrollment (Actual)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Cairo, Egypt
        • Ain Shams University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

A sample of Children with ASD who were diagnosed by Diagnostic and Statistical Manual of Mental Disorders (DSM-V) criteria.

Description

Inclusion Criteria:

  1. Age: 2 year to 8 years.
  2. Both sexes
  3. Diagnosed with autism spectrum disorders

Exclusion Criteria:

  • A history of other developmental disorders or neuropsychiatric disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
evaluate the effect of MITA application on language improvement in children with Autism.
Time Frame: baseline , after 3 months and after 6 months .
evaluation through :Autism Treatment Evaluation Checklist and Mental Synthesis Evaluation Checklist.
baseline , after 3 months and after 6 months .

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ain Shams University

Investigators

  • Study Chair: Mohamed Abd EL-Adl El-Sawy, Professor of Pediatrics, Professor of Pediatrics ain shams university
  • Study Director: Ola Ali Khalifa, professor, professor of medical genitics ain shams university
  • Study Director: Azza Mohamed Youssef, professor, Professor of developmental and behavioral pediatrics ain shams university
  • Principal Investigator: Asmaa Wafeek Abdelaziz, assistant professor, assistant prfessor of pediatrics ain shams university
  • Principal Investigator: Sarah Farid Mohamed Fahmy, Associate Proffessor, associate Professor of clinical pharmacy ain shams university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2021

Primary Completion (Actual)

January 1, 2024

Study Completion (Actual)

May 1, 2024

Study Registration Dates

First Submitted

September 20, 2024

First Submitted That Met QC Criteria

December 9, 2025

First Posted (Actual)

December 23, 2025

Study Record Updates

Last Update Posted (Actual)

December 23, 2025

Last Update Submitted That Met QC Criteria

December 9, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • technology effect on ASD child

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Clinical Trials on application called Mental Imagery Therapy for Autism (MITA)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe